Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009:2009:278762.
doi: 10.1155/2009/278762. Epub 2009 Dec 28.

Glinide, but not sulfonylurea, can evoke insulin exocytosis by repetitive stimulation: imaging analysis of insulin exocytosis by secretagogue-induced repetitive stimulations

Affiliations

Glinide, but not sulfonylurea, can evoke insulin exocytosis by repetitive stimulation: imaging analysis of insulin exocytosis by secretagogue-induced repetitive stimulations

Kyota Aoyagi et al. Exp Diabetes Res. 2009.

Abstract

To investigate the different effects between sulfonylurea (SU) and glinide drugs in insulin secretion, pancreatic beta-cells were repeatedly stimulated with SU (glimepiride) or glinide (mitiglinide). Total internal reflection fluorescent (TIRF) microscopy revealed that secondary stimulation with glimepiride, but not glucose and mitiglinide, failed to evoke fusions of insulin granules although primary stimulation with glucose, glimepiride, and mitiglinide induced equivalent numbers of exocytotic responses. Glimepiride, but not glucose and mitiglinide, induced abnormally sustained [Ca(2+)](i) elevations and reductions of docked insulin granules on the plasma membrane. Our data suggest that the effect of glinide on insulin secretory mechanisms is similar to that of glucose.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Histogram of the numbers of fusion events (/200 μm2) at 1-minute intervals after stimulation. Cells were perifused with 16.7 mM glucose (N = 16) (a), 0.5 μM mitiglinide (N = 17) (b), and 0.5 μM glimepiride (N = 11) (c) for 12.5 minutes. After the first stimulation, cells were perifused with 4 mM glucose for 15 minutes and stimulated again by the same secretagogues as in the first stimulation. Left and right columns show exocytotic responses during thefirst and second stimulations, respectively. (d) The numbers of total fusion events during the first and second stimuli. Data are represented as mean ± S.E.M per 200 μm2.
Figure 1
Figure 1
Histogram of the numbers of fusion events (/200 μm2) at 1-minute intervals after stimulation. Cells were perifused with 16.7 mM glucose (N = 16) (a), 0.5 μM mitiglinide (N = 17) (b), and 0.5 μM glimepiride (N = 11) (c) for 12.5 minutes. After the first stimulation, cells were perifused with 4 mM glucose for 15 minutes and stimulated again by the same secretagogues as in the first stimulation. Left and right columns show exocytotic responses during thefirst and second stimulations, respectively. (d) The numbers of total fusion events during the first and second stimuli. Data are represented as mean ± S.E.M per 200 μm2.
Figure 2
Figure 2
[Ca2+]i responses to repetitive stimulations. Cells were perifused with 4 mM glucose and then stimulated with 16.7 mM glucose (a), 0.5 μM mitiglinide (b), or 0.5 μM glimepiride (c) for 12.5 minutes. After the first stimulation, cells were perifused with 4 mM glucose for 15 minutes and stimulated again by the same secretagogues as in the first stimulation. Data are represented as a ratio of the fluorescence intensity expressed as F/F 0, where F 0 is the ratio of 340 to 380 nm at the baseline. (mean + S.E.M., N = 9, 7, and 7 for 16.7 mM glucose, mitiglinide, and glimepiride, resp.).
Figure 3
Figure 3
The numbers of docked insulin granules just before the second stimulation. Results are mean ± S.E.M percentage of the numbers of docked insulin granules just before the first stimulation (N = 12, 9, and 10 for 16.7 mM glucose, mitiglinide, and glimepiride, resp.).

Similar articles

Cited by

References

    1. Quast U, Stephan D, Bieger S, Russ U. The impact of ATP-sensitive K+ channel subtype selectivity of insulin secretagogues for the coronary vasculature and the myocardium. Diabetes. 2004;53(supplement 3):S156–S164. - PubMed
    1. Kawai J, Ohara-Imaizumi M, Nakamichi Y, et al. Insulin exocytosis in Goto-Kakizaki rat β-cells subjected to long-term glinide or sulfonylurea treatment. Biochemical Journal. 2008;412(1):93–101. - PubMed
    1. Ohnota H, Koizumi T, Tsutsumi N, Kobayashi M, Inoue S, Sato F. Novel rapid- and short-acting hypoglycemic agent, a calcium(2s)-2-benzyl-3-(cis-hexahydro-2-isoindolinylcarbonyl) propionate (KAD-1229) that acts on the sulfonylurea receptor: comparison of effects between KAD-1229 and gliclazide. The Journal of Pharmacology and Experimental Therapeutics. 1994;269(2):489–495. - PubMed
    1. Karam JH, Sanz E, Salamon E, Nolte MS. Selective unresponsiveness of pancreatic B-cells to acute sulfonylurea stimulation during sulfonylurea therapy in NIDDM. Diabetes. 1986;35(12):1314–1320. - PubMed
    1. Rabuazzo AM, Buscema M, Vinci C, et al. Glyburide and tolbutamide induce desensitization of insulin release in rat pancreatic islets by different mechanisms. Endocrinology. 1992;131(4):1815–1820. - PubMed

Publication types

MeSH terms